Multivariate analyses for outcomes after UCBT for adults with hematologic malignancies according to the use of ATG in the Cy/Flu/TBI200 regimen
Characteristics . | 3-Year OS . | 3-Year NRM . | Acute 3-4 GVHD . | ||||||
---|---|---|---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
ATG in conditioning | |||||||||
No | 1 | [1.19-2.41] | .003 | 1 | [1.16-2.43] | .0009 | 1 | [0.17-0.55] | .000 |
Yes | 1.69 | 1.68 | 0.31 |
Characteristics . | 3-Year OS . | 3-Year NRM . | Acute 3-4 GVHD . | ||||||
---|---|---|---|---|---|---|---|---|---|
HR . | 95% CI . | P . | HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
ATG in conditioning | |||||||||
No | 1 | [1.19-2.41] | .003 | 1 | [1.16-2.43] | .0009 | 1 | [0.17-0.55] | .000 |
Yes | 1.69 | 1.68 | 0.31 |